Tiotropium, a novel muscarinic M3 receptor antagonist, improved symptoms of chronic obstructive pulmonary disease complicated by chronic heart failure

Circulation Journal

Volumn 70, Issue 12, 2006, Pages 1658-1660

  Kato, Mahoto ^a   Komamura, Kazuo ^a   Kitakaze, Masafumi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Brain natriuretic peptide; Chronic heart failure; Chronic obstructive pulmonary disease; M3 muscarinic receptor antagonist; Tiotropium

Indexed keywords

TIOTROPIUM BROMIDE;

ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; DRUG EFFECT; DRUG EFFICACY; HEART FAILURE; HUMAN; MALE; SYMPTOMATOLOGY;

AGED; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES;

EID: 33751418333     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1658     Document Type: Article

References (17)

1. Rutten FH, Cramer MJM, Grobbee DE, Sachs APE, Kirkels JH, Lammers JWJ, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005; 26: 1887-1894.
2. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003; 42: 1226-1233.
3. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente medical care program. Chest 2005; 128: 2068-2075.
4. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-2646.
5. Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia: A new application of tissue Doppler imaging. Circulation 1998; 98: 1644-1650.
6. Fabbri LM, Hurd SS. GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of COPD 2003 update (Editorial). Eur Resp J 2003; 22: 1-2.
7. Molken MR, Roos B, Noord JA. An empirical comparison of the St George's respiratory questionnaire (SGRQ) and the chronic respiratory disease questionnaire (CRQ) in a clinical trial setting. Thorax 1999; 54: 995-1003.
8. Henriksen JH, Christensen NJ, Kok-Jensen A, Christiansen I. Increased plasma noradrenaline concentration in patients with chronic obstructive lung disease: Relation to hemodynamics and blood gases. Scand J Clin Lab Invest 1980; 40: 419-427.
9. Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, et al. Beta-blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000; 139: 596-608.
10. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-280.
11. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995; 26: 1257-1263.
12. Casaburi R, Mahler DA, Jones PW, Wanner A, SanPedro G, ZuWallack RL, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 217-224.
13. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006; 47: 742-748.
14. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: Scientific review. JAMA 2003; 290: 2301-2312.
15. Virolainen J, Ventila M, Turto H, Kupari M. Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 1995; 79: 455-460.
16. Katragadda S, Xie A, Puleo D, Skatrud JB, Morgan BJ. Neural mechanism of the pressor response to obstructive and nonobstructive apnea. J Appl Physiol 1997; 83: 2048-2054.
17. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. BMJ 2005; 330: 625-633.